{
  "type": "hyp",
  "text": "Overexpression of an activated form of Rho enhances AP-1 activity in Jurkat T cells. The effect of Rho on AP-1 is independent of the mitogen-activated protein kinase pathway as a dominant-negative MEK and a MEK inhibitor (PD98059)\n",
  "self": {
    "NER": {
      "answers": [
        "Jurkat",
        "MEK",
        "MEK"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What type of T cells is activated by Rho?",
          "What is Rho an inhibitor of?",
          "What is Rho an inhibitor of?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Overexpression",
        "an activated form",
        "Rho",
        "AP-1 activity",
        "Jurkat T cells",
        "The effect",
        "Rho",
        "the mitogen-activated protein kinase pathway",
        "a dominant-negative MEK",
        "a MEK inhibitor",
        "(PD98059"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What enhances AP-1 activity in Jurkat T cells?",
          "What enhances AP-1 activity in Jurkat T cells?",
          "What is the dominant-negative MEK?",
          "What does Rho enhance in Jurkat T cells?",
          "What type of cells does Rho enhance AP-1 activity?",
          "What is independent of the mitogen-activated protein kinase pathway?",
          "What is the dominant-negative MEK?",
          "What is the effect of Rho independent of?",
          "What is the effect of Rho on AP-1 independent of?",
          "What is PD98059?",
          "What is the name of the MEK inhibitor that binds to AP-1?"
        ]
      }
    }
  },
  "asked": {
    "Rho is a dominant-negative of what?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "MEK",
        "answerability": 0.9217740893363953,
        "ground_truth": {
          "MEK": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What is independent of the mitogen-activated protein kinase pathway?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "The effect of Rho on AP-1",
        "answerability": 0.9426847696304321,
        "ground_truth": {
          "The effect": {
            "bertscore": 0.7279186844825745,
            "f1": 0.33333333333333337
          }
        }
      }
    },
    "What is the dominant-negative MEK and MEK inhibitor?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "Rho",
        "answerability": 0.8263753056526184,
        "ground_truth": {
          "Rho": {
            "bertscore": 0.9999999403953552,
            "f1": 1.0
          }
        }
      }
    },
    "What is the effect of Rho on AP-1 independent of?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "the mitogen-activated protein kinase pathway",
        "answerability": 0.9936715364456177,
        "ground_truth": {
          "the mitogen-activated protein kinase pathway": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What is Rho an inhibitor of?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.4005032181739807,
        "ground_truth": {
          "a dominant-negative MEK": {
            "bertscore": 0.6594237089157104,
            "f1": 0
          }
        }
      }
    },
    "What is Rho's effect on AP-1 independent of?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "the mitogen-activated protein kinase pathway",
        "answerability": 0.99533611536026,
        "ground_truth": {
          "a MEK inhibitor": {
            "bertscore": 0.7111818790435791,
            "f1": 0
          }
        }
      }
    },
    "What is the name of the MEK inhibitor that Rho acts as?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "PD98059",
        "answerability": 0.9144828915596008,
        "ground_truth": {
          "(PD98059": {
            "bertscore": 0.8944063782691956,
            "f1": 1.0
          }
        }
      }
    }
  }
}